Da-Yong Lu* and Bin Xu
School of Life Sciences, Shanghai University, Shanghai, PRC
*Corresponding Author: Da-Yong Lu, School of Life Sciences, Shanghai University, Shanghai, PRC.
Received: April 19, 2023; Published: June 16, 2023
Cancer bone metastasis was common for cancers. It is very painful for patients. Drug treatment needs to improve for both growth inhibition and symptom management. To promote therapeutic paradigms, clinical drug treatment should be specified. This editorial discusses bone cancer metastasis treatment in personalized medicine.
Keywords:Bone Cancer; Neoplasm Metastasis; Drug Treatment; Clinical Trial
Citation: Da-Yong Lu and Bin Xu. “Cancer Bone Metastasis, Circulation Biomarkers”.Acta Scientific Orthopaedics 6.7 (2023): 35-37.
Copyright: © 2023 Da-Yong Lu and Bin Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.